Safety and efficacy of paliperidone extended-release in acute and maintenance treatment of schizophrenia.
about
Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases.Paliperidone: 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]eth-yl}-9-hy-droxy-2-methyl-1,6,7,8,9,9a-hexa-hydro-pyrido[1,2-a]pyrimidin-4-one.An update of safety of clinically used atypical antipsychotics.Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.Paliperidonium nitrate.
P2860
Safety and efficacy of paliperidone extended-release in acute and maintenance treatment of schizophrenia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Safety and efficacy of paliper ...... ce treatment of schizophrenia.
@en
type
label
Safety and efficacy of paliper ...... ce treatment of schizophrenia.
@en
prefLabel
Safety and efficacy of paliper ...... ce treatment of schizophrenia.
@en
P2860
P356
P1476
Safety and efficacy of paliper ...... ce treatment of schizophrenia.
@en
P2093
Edoardo Spina
Rosalia Crupi
P2860
P356
10.4137/JCNSD.S1607
P577
2011-02-14T00:00:00Z